Veradigm files late notice for FY2025 Form 10-K as SEC reporting delays persist
Allscripts Healthcare Solutions, Inc. MDRX | 4.60 | +0.88% |
Veradigm filed a Form 12b-25 saying it could not file its annual report on Form 10-K for the year ended Dec. 31, 2025 by the deadline without unreasonable effort or expense. The company said prior financial statements for 2021 and certain interim periods in 2021 and 2022 should no longer be relied upon due to revenue misstatements tied to internal control failures. It also said its 2020 financial statements should no longer be relied upon because of misstatements identified during audit procedures. Veradigm said it has not filed multiple periodic reports for 2023 through 2025, including the 2024 Form 10-K and quarterly reports for 2025. The company said Nasdaq delisted its common stock after determining it remained noncompliant with filing and annual meeting requirements.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Veradigm Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-109475), on March 17, 2026, and is solely responsible for the information contained therein.
